BioSpace News Archive

Biotech Beach

Regulus Announces Successful Restructuring of Sanofi Collaboration

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that it has amended and restructured its Collaboration and License Agreement with Sanofi (

November 6, 2018
·
6 min read
Business

Agenus Reports Third Quarter 2018 Financial Results and Provides Corporate Update

130 patients treated with Agenus’ PD-1 & CTLA-4; clinical benefit >63% treated

November 6, 2018
·
6 min read
Deals

Avista Capital Partners to Acquire the Extended Topicals and Dermatology Business of G&W Laboratories

Avista Establishes a New Pharmaceuticals Platform

November 6, 2018
·
5 min read
BioForest

ProMIS Neurosciences Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer’s Disease

Narrated white paper reveals lessons learned from 15 years of drug development; pressing need to selectively target the toxic oligomer.

November 6, 2018
·
4 min read
FSD Pharma Announces Positive ISA Report for “Steady Stomach” CBD Combination

FSD Pharma Inc. announced today that its strategic R&D partner, SciCann Therapeutics Inc. (“SciCann”) received a positive International Search Authority (ISA) report from the Patent Cooperation Treaty (PCT) for its SCN-001 cannabidiol (CBD) combination therapy, the basis of its “Steady Stomach” product.

November 6, 2018
·
5 min read
Business

Dicerna to Participate in Upcoming November 2018 Investor Conferences

Dicerna Pharmaceuticals, Inc. today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will participate in three investor conferences in November.

November 6, 2018
·
2 min read
Genetown

Ra Pharmaceuticals to Present at Upcoming November 2018 Investor Conferences

Ra Pharmaceuticals, Inc. today announced that senior management will present at the following upcoming investor conferences

November 6, 2018
·
1 min read
Business

Catalent, Inc. Reports First Quarter Fiscal 2019 Results

Q1'19 revenue of $551.8 million increased 1% as-reported, or 3% in constant currency, from the prior-year period.

November 6, 2018
·
28 min read
Genetown

KalVista Pharmaceuticals to Present at Upcoming Investor Conferences

KalVista Pharmaceuticals, Inc. today announced that it will present a corporate overview at the following upcoming investor conferences.

November 6, 2018
·
2 min read
Policy

Partner Therapeutics Receives FDA Orphan Drug Designation for Leukine® for the Treatment of Pulmonary Alveolar Proteinosis

Partner Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Leukine®.

November 6, 2018
·
3 min read